This is a preprint.
A causal link between autoantibodies and neurological symptoms in long COVID
- PMID: 38947091
- PMCID: PMC11213106
- DOI: 10.1101/2024.06.18.24309100
A causal link between autoantibodies and neurological symptoms in long COVID
Abstract
Acute SARS-CoV-2 infection triggers the generation of diverse and functional autoantibodies (AABs), even after mild cases. Persistently elevated autoantibodies have been found in some individuals with long COVID (LC). Using a >21,000 human protein array, we identified diverse AAB targets in LC patients that correlated with their symptoms. Elevated AABs to proteins in the nervous system were found in LC patients with neurocognitive and neurological symptoms. Purified Immunoglobulin G (IgG) samples from these individuals reacted with human pons tissue and were cross-reactive with mouse sciatic nerves, spinal cord, and meninges. Antibody reactivity to sciatic nerves and meninges correlated with patient-reported headache and disorientation. Passive transfer of IgG from patients to mice led to increased sensitivity and pain, mirroring patient-reported symptoms. Similarly, mice injected with IgG showed loss of balance and coordination, reflecting donor-reported dizziness. Our findings suggest that targeting AABs could benefit some LC patients.
Keywords: Autoantibodies; Chronic Pain; Long COVID; SARS-CoV-2.
Conflict of interest statement
Declaration of interests A. I. co-founded RIGImmune, Xanadu Bio and PanV and is a member of the Board of Directors of Roche Holding Ltd and Genentech. All other authors declare no competing interests.
Figures




References
-
- Ford Nd Fau - Slaughter D., Slaughter D Fau - Edwards D., Edwards D Fau - Dalton A., Dalton A Fau - Perrine C., Perrine C Fau - Vahratian A., Vahratian A Fau - Saydah S., and Saydah S. (2023). Long COVID and Significant Activity Limitation Among Adults, by Age - United States, June 1–13, 2022, to June 7–19, 2023. MMWR Morb Mortal Wkly Rep 72, 866–870. 10.15585/mmwr.mm7232a3. - DOI - PMC - PubMed
-
- Ayoubkhani D.A.-O., Bosworth M.L., King S., Pouwels K.B., Glickman M., Nafilyan V.A.-O.X., Zaccardi F., Khunti K.A.-O., Alwan N.A.-O., and Walker A.S. (2022). Risk of Long COVID in People Infected With Severe Acute Respiratory Syndrome Coronavirus 2 After 2 Doses of a Coronavirus Disease 2019 Vaccine: Community-Based, Matched Cohort Study. Open Forum Infect Dis 9, ofac464. 10.1093/ofid/ofac464. - DOI - PMC - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources